Amgen Launches AMGEVITA™ (Biosimilar Adalimumab) In Markets Across Europe

Go back to Amgen Launches AMGEVITA™ (Biosimilar Adalimumab) In Markets Across Europe
Amgen Inc (NASDAQ: AMGN) Delayed: 442.84 +4.72 (1.08%)
Previous Close $438.12    52 Week High $176.85 
Open $440.65    52 Week Low $133.64 
Day High $445.57    P/E 66.69 
Day Low $435.00    EPS $6.64 
Volume 2,285,556